IP Library Granted Patent US 12,258,593
Granted Patent B2
US 12,258,593 · App. 18/091,687 · Granted Mar 25, 2025

Hydrolase and method for producing (1S,2S)-1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid using same

Inventors: Toyokazu Yoshida (Gifu, JP); Koichi Ishida (Gifu, JP); Ryoma Miyake (Tokyo, JP); Takanobu Iura (Tokyo, JP); Hiroshi Kawabata (Tokyo, JP)
Assignee: UBE CORPORATION
C12N9/18C12P7/62C12P41/00C12Y301/01
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,258,593
App. No.
18/091,687
Granted
Mar 25, 2025
Kind
B2
Abstract

The present invention provides a novel hydrolase that can industrially produce optically highly pure (1S,2S)-1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid with high efficiency at low costs, and a production method using the hydrolase.

Claims (35)

1. A method for producing (1S,2S)-1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid, comprising bringing a hydrolase, a microorganism or cell having an ability to produce the hydrolase, a and/or a culture solution containing the hydrolase into contact with dialkyl 2-vinylcyclopropane-1,1-dicarboxylic acid represented by formula (I) to produce (1S,2S)-1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid represented by formula (II),

wherein the hydrolase comprises a polypeptide of the following (a), (b), or (c):

(a) a polypeptide consisting of an amino acid sequence resulting from the deletion, insertion, substitution, and/or addition of 1 to 50 amino acids in the amino acid sequence shown in SEQ ID NO: 4 or 6, and an activity to catalyze the reaction shown in the formula (1):

wherein R is an alkyl group having 1 to 6 carbon atoms, and a ratio of Syn isomer to Anti isomer in formula (II) is equal to or less than 0.2%;

(b) a polypeptide consisting of an amino acid sequence with not less than 95% sequence identity with the amino acid sequence shown in SEQ ID NO: 4 or 6, and an activity to catalyze the reaction shown in formula (1);

(c) a polypeptide consisting of an amino acid sequence with not less than 90% sequence identity with the amino acid sequence shown in SEQ ID NO: 4 or 6, wherein the amino acid sequence comprises:

(i) 5 consecutive residues DATRG corresponding to residues 75-79 of SEQ ID NO: 4 and residues 80-84 of SEQ ID NO: 6;

ii 4 consecutive residues PYGF corresponding to residues 132-135 of SEQ ID NO: 4 and residues 136-139 of SEQ ID NO: 6;

iii 4 consecutive residues NWPG corresponding to residues 222-225 of SEQ ID NO: 4 and residues 226-229 of SEQ ID NO: 6; and/or

(iv) 5 consecutive residues PGWPG corresponding to residues 285-289 of SEQ ID NO: 4 and residues 289-293 of SEQ ID NO: 6.

2. The production method according to claim 1 , wherein R in the formula (1) is an ethyl group.

3. The production method according to claim 1 , wherein the microorganism or cell is a microorganism or cell transformed with a nucleic acid encoding the hydrolase comprising the polypeptide of following (a), (b), or (c).

4. The production method according to claim 1 , wherein the microorganism or cell is a microorganism or cell transformed with a nucleic acid comprising a base sequence of the following (d), (e), (f), or (g):

(d) the base sequence shown in SEQ ID NO: 3 or 5;

(e) a nucleic acid consisting of a base sequence resulting from the substitution, deletion, and/or addition of 1 to 150 bases in the base sequence shown in SEQ ID NO: 3 or 5, and encoding a polypeptide having an activity to catalyze the reaction shown in formula (1);

wherein R is an alkyl group having 1 to 6 carbon atoms in formula (1), and wherein the ratio of Syn isomer to Anti isomer in formula (II) is equal to or less than 0.2%;

(f) a nucleic acid consisting of a base sequence having not less than-60% of 90% sequence identity with the base sequence shown in SEQ ID NO: 3 or 5, and encoding a polypeptide having an activity to catalyze the reaction shown in formula (1);

(g) a nucleic acid having a base sequence that hybridizes with a complementary strand of the base sequence shown in SEQ ID NO: 3 or 5 under the condition of washing once at 60° C., 1×SSC, and 0.1% SDS, and encoding a polypeptide having an activity to catalyze the reaction shown informula (1).

5. A method for producing (1S,2S)-1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid, comprising bringing a treated product of a microorganism or cell having the ability to produce a hydrolase into contact with dialkyl 2-vinylcyclopropane-1,1-dicarboxylic acid represented by formula (I) to produce (1S,2S)-1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid represented by formula (II),

wherein the hydrolase comprises a polypeptide of the following (a), (b), or (c):

(a) a polypeptide consisting of an amino acid sequence resulting from the deletion, insertion, substitution, and/or addition of 1 to 50 amino acids in the amino acid sequence shown in SEQ ID NO: 4 or 6, and an activity to catalyze the reaction shown in formula (1):

wherein R is an alkyl group having 1 to 6 carbon atoms, and a ratio of Syn isomer to Anti isomer in formula (II) is equal to or less than 0.2%;

(b) a polypeptide consisting of an amino acid sequence with not less than 95% sequence identity with the amino acid sequence shown in SEQ ID NO: 4 or 6, and an activity to catalyze the reaction shown in formula (1);

(c) a polypeptide consisting of an amino acid sequence with not less than 90% sequence identity with the amino acid sequence shown in SEQ ID NO: 4 or 6, wherein the amino acid sequence comprises:

(i) 5 consecutive residues DATRG corresponding to residues 75-79 of SEQ ID NO: 4 and residues 80-84 of SEQ ID NO: 6;

(ii) 4 consecutive residues PYGF corresponding to residues 132-135 of SEQ ID NO: 4 and residues 136-139 of SEQ ID NO: 6;

(iii) 4 consecutive residues NWPG corresponding to residues 222-225 of SEQ ID NO: 4 and residues 226-229 of SEQ ID NO: 6; and/or

(iv) 5 consecutive residues PGWPG corresponding to residues 285-289 of SEQ ID NO: 4 and residues 289-293 of SEQ ID NO: 6.

6. The production method according to claim 5 , wherein R in the formula (1) is an ethyl group.

7. The production method according to claim 5 , wherein the microorganism or cell is a microorganism or cell transformed with a nucleic acid comprising a base sequence of the following (d), (e), (f), or (g):

(d) the base sequence shown in SEQ ID NO: 3 or 5;

(e) a nucleic acid consisting of a base sequence resulting from the substitution, deletion, and/or addition of 1 to 150 bases in the base sequence shown in SEQ ID NO: 3 or 5, and encoding a polypeptide having an activity to catalyze the reaction shown in formula (1):

wherein R is an alkyl group having 1 to 6 carbon atoms in formula (1), and the ratio of Syn isomer to Anti isomer in formula (II) is equal to or less than 0.2%;

(f) a nucleic acid consisting of a base sequence having not less than 90% of sequence identity with the base sequence shown in SEQ ID NO: 3 or 5, and encoding a polypeptide having an activity to catalyze the reaction shown in formula (1);

(g) a nucleic acid having a base sequence that hybridizes with a complementary strand of the base sequence shown in SEQ ID NO: 3 or 5 under the condition of washing once at 60° C., 1×SSC, and 0.1% SDS, and encoding a polypeptide having an activity to catalyze the reaction shown in formula (1).

Assignments (3)
MERGER Recorded Feb 14, 2025
From: API CORPORATION
To: UBE CORPORATION
Reel/Frame 070235/0474 →
CHANGE OF ADDRESS Recorded Jun 21, 2023
From: API CORPORATION
To: API CORPORATION
Reel/Frame 064103/0580 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 30, 2022
From: YOSHIDA, TOYOKAZU; ISHIDA, KOICHI; MIYAKE, RYOMA; IURA, TAKANOBU; KAWABATA, HIROSHI
To: API CORPORATION
Reel/Frame 062245/0247 →
Priority Claims (1)
JP 2018-070188 · Mar 30, 2018 · national
Continuity (2)
Division 17043339
Related Publication 20230323317A1 · Oct 12, 2023
References Cited (24)
US 9029107B2 · Kawabata · 2015 [cited by examiner]
US 20130096339A1 · Asuma et al. · 2013 [cited by applicant]
US 20130130338A1 · Kawabata et al. · 2013 [cited by applicant]
EP 2796562A1 · 2014 [cited by applicant]
JP 5613660B2 · 2014 [cited by applicant]
JP 5657560B2 · 2015 [cited by applicant]
WO WO2012029819A1 · 2012 [cited by applicant]
Fransceus (J Ind Microbiol Biotechnol. May 2017;44(4-5):687-695. [cited by examiner]
Sanavia (Computational and Structural Biotechnology Journal, vol. 18, 2020, pp. 1968-1979. [cited by examiner]
F4CQZ7-PSEUX. UniProtKB/TrEMBL Database. Nov. 10, 2016. [cited by examiner]
A0A0M8MNS3_9MICO. UniProtKB/TrEMBL Database. Sep. 27, 2027. [cited by examiner]
ISR for PCT/JP2019/013926, dated Jun. 18, 2019, (w/ translation). [cited by applicant]
Written Opinion of the ISA for PCT/JP2019/013926, dated Jun. 18, 2019, (w/ translation). [cited by applicant]
EESR for EP App. No. 19777561.2, dated Jan. 10, 2022. [cited by applicant]
“Alpha/beta hydrolase {EC0:00003131 EMBL:OZC62876.1}”, A0A259Y6X7, [online], UniProtKB, https://www.uniprot.org/uniprot/A0A259Y6X7.txt?version=3, Feb. 28, 2018. [cited by applicant]
“Alpha/beta hydrolase {EC0:00003131 EMBL:KQU47217.1}”, A0A0Q6JV16, [online], UniProtKB, https://www.uniprot.org/uniprot/A0A0Q6JV16.txt?version=11, Feb. 28, 2018. [cited by applicant]
“Alpha/beta hydrolase [Pseudonocardia dioxanivorans]”, WP_013673631, [online], National Center for Biotechnology Information, https://www.ncbi.nlm.nih.gov/protein/WP_013673631, May 18, 2013. [cited by applicant]
“Alpha/beta hydrolase [Microbacterium chocolatum]”, WP_053548180, [online], National Center for Biotechnology Information, https://www.ncbi.nlm.nih.gov/protein/92489447?sat=47&satkey=7881781, Sep. 3, 2015. [cited by applicant]
Fliche et al., “Enantioselective Synthesis of (1R,2S) and (1S,2S) Dehydrocoronamic Acids,” Synth. Commun. vol. 24, No. 20, pp. 2873-2876 (1994). [cited by applicant]
Database UniProt [Online], UniParc, Database accession No. UPI000B9AD34C, Dec. 20, 2017, XP002804883. [cited by applicant]
Database UniProt [Online], UniParc, Database accession No. UPI00070AAE76, Nov. 13, 2015, XP002804886. [cited by applicant]
Database UniProt [Online], UniParc, Database accession No. UPI00020740DB, Jun. 28, 2011, XP002804893. [cited by applicant]
Studer, “Residue mutations and their impact on protein structure and function: detecting beneficial and pathogenic changes,” Biochem. J. (2013) 449, 581-594. [cited by applicant]
Office Action for CN App. No. 201980022337.3, dated Jan. 26, 2024 (w/ translation). [cited by applicant]